DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia

Nature Genetics
Christopher C OakesChristoph Plass

Abstract

Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.

References

Feb 3, 1997·The Journal of Experimental Medicine·S LebecqueY J Liu
Dec 19, 2002·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Richard Desper, Olivier Gascuel
Oct 23, 2004·Science·UNKNOWN ENCODE Project Consortium
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Aug 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sasan ZandiMikael Sigvardsson
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Murali GururajanSubbarao Bondada
Dec 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yuri PekarskyCarlo M Croce
Jan 19, 2010·Bioinformatics·Heng Li, Richard Durbin
Mar 12, 2010·Genome Research·Andrew E TeschendorffMartin Widschwendter
May 4, 2010·Nature Biotechnology·Cory Y McLeanGill Bejerano
Jul 24, 2010·British Journal of Haematology·Lena ReindlClaudia Haferlach
Sep 25, 2010·Seminars in Cancer Biology·Anders RosénRichard Rosenquist
Mar 29, 2011·Nature·Jason ErnstBradley E Bernstein
May 25, 2011·The Journal of Experimental Medicine·Lynn M Heltemes-HarrisMichael A Farrar
Oct 1, 2009·Epigenomics·Marina BibikovaKevin L Gunderson
Dec 1, 2011·Epigenomics·Cristina FloreanMarc Diederich
Oct 24, 2012·The Journal of Experimental Medicine·Marc SeifertRalf Küppers
Nov 24, 2012·Leukemia·V BohleR Küppers
Feb 13, 2013·Nature Reviews. Genetics·Zachary D Smith, Alexander Meissner
Jun 14, 2013·Nature Reviews. Cancer·Winston Timp, Andrew P Feinberg
Aug 9, 2013·Nature·Michael J ZillerAlexander Meissner
Sep 28, 2013·Nature Protocols·Qi WangDieter Weichenhan
Oct 19, 2013·Science·Maya KasowskiMichael Snyder
Dec 21, 2013·Cancer Discovery·Christopher C OakesChristoph Plass
Dec 29, 2013·Nucleic Acids Research·Montse GustemsWolfgang Hammerschmidt
Mar 29, 2014·Nature·Robin AnderssonAlbin Sandelin
May 13, 2014·Experimental Hematology·Koen H M PrangeJoost H A Martens
Jun 13, 2014·Cancer Discovery·Frederik DammOlivier A Bernard
Jul 30, 2014·Cell Reports·David BrocksUNKNOWN ICGC Early Onset Prostate Cancer Project
Aug 12, 2014·Science·David Lara-AstiasoIdo Amit

❮ Previous
Next ❯

Citations

Apr 8, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Pradeep Kumar KopparapuMeena Kanduri
Aug 9, 2016·Leukemia·M Seifert, R Küppers
Sep 15, 2016·Epigenomics·Wolfgang A Schulz, Wolfgang Goering
Sep 16, 2016·Nature Reviews. Genetics·Peter A JonesStephen Baylin
Aug 26, 2016·Leukemia·M SłabickiT Zenz
Apr 27, 2017·British Journal of Haematology·Hussein GhamlouchOlivier A Bernard
Mar 30, 2017·Chemical Society Reviews·Yuqi ChenXiang Zhou
Apr 14, 2016·Cancer Cell·Tali MazorJoseph F Costello
Jan 18, 2017·Cold Spring Harbor Perspectives in Medicine·Noelia Purroy, Catherine J Wu
Dec 21, 2016·The Journal of Investigative Dermatology·Leonie RoosJordana T Bell
Jan 20, 2017·Nature Reviews. Disease Primers·Thomas J KippsKanti Rai
Sep 19, 2017·International Journal of Cancer. Journal International Du Cancer·Christine WolfDaniel Mertens
Dec 12, 2017·The Journal of Clinical Investigation·Sascha DietrichThorsten Zenz
Dec 21, 2017·Nature Communications·Daniel B LipkaChristoph Plass
Jul 14, 2017·British Journal of Pharmacology·Pavlína Janovská, Vítězslav Bryja
Jul 25, 2018·Blood·Christopher C Oakes, Jose I Martin-Subero
Nov 18, 2018·International Journal of Cancer. Journal International Du Cancer·Nikos PapakonstantinouKostas Stamatopoulos
Jul 27, 2017·International Journal of Cancer. Journal International Du Cancer·Irina BureEvgeny A Moskalev
Feb 16, 2019·Omics : a Journal of Integrative Biology·Kevin Dzobo
Jan 24, 2019·Blood·Charlotte M Niemeyer, Christian Flotho
Jan 13, 2018·G3 : Genes - Genomes - Genetics·Christopher G DuncanPaul A Wade
Mar 16, 2019·Immunological Reviews·Yan Zhang, Kim L Good-Jacobson
Oct 7, 2017·Nature Medicine·Adolfo A Ferrando, Carlos López-Otín
Feb 8, 2019·Blood·Satyen H Gohil, Catherine J Wu
Jun 22, 2018·Molecular Systems Biology·Ricard ArgelaguetOliver Stegle
May 24, 2019·Molecular Systems Biology·Jan-Philipp MallmKarsten Rippe
Jan 20, 2018·Nature Reviews. Cancer·Jan A Burger, Adrian Wiestner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.